1. Academic Validation
  2. A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem

A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem

  • J Hum Genet. 2005;50(5):230-234. doi: 10.1007/s10038-005-0243-y.
Avihu Boneh 1 2 Stanley H Korman 3 Kenichi Sato 4 Junko Kanno 4 Yoichi Matsubara 4 Israela Lerer 5 Ziva Ben-Neriah 5 Shigeo Kure 4
Affiliations

Affiliations

  • 1 Department of Human Genetics, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel. [email protected].
  • 2 Metabolic Service, Genetic Health Services Victoria, The Murdoch Children's Research Institute, Royal Children's Hospital, Flemington Road, Melbourne, Victoria, 3052, Australia. [email protected].
  • 3 Department of Clinical Biochemistry, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • 4 Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan.
  • 5 Department of Human Genetics, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
Abstract

Glycine encephalopathy (GE) (non-ketotic hyperglycinemia) is an autosomal recessive neurometabolic disease caused by defective activity of the glycine cleavage system. Clinically, patients present usually in the neonatal period with hypotonia, encephalopathy, hiccups and breath arrests with or without overt seizures. GE is considered rare, but its incidence is relatively high in several geographical areas around the world. We report a novel mutation causing GE in six extended Arab families, all from a small suburban village (population 5,000). A methionine to threonine change in the initiation codon of the glycine decarboxylase gene led to markedly reduced glycine decarboxylase mRNA levels and abolished glycine cleavage system activity.

Figures